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I. Introduction
5-Aminolevulinic acid (ALA) is the first com-
pound of the biosynthetic pathway of heme. It has 
been used in photodynamic therapy for skin dis-
eases such as cutaneous carcinoma and intractable 
acne 1–4). Recently, some cosmetics including ALA 
have been launched to the market. 
Skin has an outermost thin layer, stratum 
corneum, and underlying viable epidermis and 
dermis. Since the stratum corneum is highly hy-
drophobic, dry, and a percutaneous barrier, hy-
drophilic compounds are inferior to hydrophobic 
compounds in permeating through the stratum 
corneum 5). When ALA is topically applied to skin, 
it is hard for ALA to permeate through the stratum 
corneum, because ALA is hydrophilic. Thus, ALA 
skin permeation needs to be improved. 
Liposomes are defined as a structure com-
posed of lipid bilayer membranes with an inner 
core of water phase. They can incorporate wa-
ter-insoluble compounds in the lipid bilayers and 
water-soluble compounds in the inner core 6). Li-
posomes are well known as a drug carrier to en-
hance skin permeation 7). In the present study, we 
prepared ALA-loaded liposomes and determined 
in vitro ALA permeation through Yucatan micro-
pig (YMP) full-thickness skin using a Franz-type 
diffusion cell, demonstrating their ability to en-
hance ALA skin permeation. 
II. Experimental 
1. Materials 
L-α-dipalmitoylphosphatidylcholine (DPPC, 
99.7%), cholesterol (99%), and 5-aminolevulinic 
acid hydrochloride (ALA, 98%) were purchased 
from NOF. Co., SIGMA, and Cosmo Bio Co., 
Ltd., respectively. They were used without further 
purification. Yucatan micropig (YMP) full-thick-
ness skin from CHARLES RIVER LABORATO-
RIES JAPAN, INC. was used for in vitro skin per-
meation measurements. Distilled water was used 
for all the measurements. 
2. Preparation of ALA-loaded liposomes 
ALA-loaded liposomes were prepared using 
Bangham’s method 8). A 1.83 x 10-2 g of DPPC 
and 3.8 x 10-3 g of cholesterol were dissolved in 5 
mL of chloroform in a test tube. The solvent was 
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evaporated under N2 gas, and a thin lipid film was 
formed on the wall of the test tube. To remove 
the residual solvent completely, the test tube was 
allowed to stand in a desiccator under reduced 
pressure. After a 5 mL of 0.28 M aqueous ALA 
solution was added into the test tube, the test tube 
was kept for 5 min at 60 °C, then agitated on a vor-
tex mixer for 5 min to give liposomes encapsulat-
ing ALA. The liposome dispersion was extruded 
through Millipore filters (Whatman Co.) having 
100 nm pore diameter with an extruder (Lipex 
Biomembranes Inc.) to give homogeneously sized 
liposomes. Finally, the liposome dispersion was 
dialyzed against 0.9 wt% aqueous sodium chloride 
solution for a few hours, with the solution changed 
every hour. After the dialysis, the concentration of 
ALA in the aqueous sodium chloride solution was 
measured to confirm no presence of free ALA in 
the solution. 
3. Measurement of ALA concentration 
The concentration of ALA was measured by 
the fluorometric method reported by Okayama 9). 
A 50 µL of ALA solution was treated with a mix-
ture of 3.5 mL of acethyl acetone, ethanol, and 
water (15:10:75 in volume ratio) containing 4 g 
of sodium chloride per liter, and then with 450 µL 
of 85 ml/L aqueous formaldehyde solution. The 
treated solution was heated in boiling water for 30 
min and was cooled under iced water for 5 min. 
These reactions eventually gave us the fluores-
cent ALA derivative, 2-methyldeneamin-3,5-di-
acetyl-4,6-dimethylphenylpropionic acid. The 
fluorescence intensity of the ALA derivative was 
measured with a fluorescence spectrophotometer 
(FP-6500, JASCO Co.). The excitation and emis-
sion wavelengths were 363 and 465 nm, respec-
tively. 
4. Trapping efficiency of liposomes for ALA 
After the ALA-loaded liposome dispersion 
was dialyzed, the liposome was broken by ad-
dition of ethanol (the volume ratio between the 
liposome dispersion and ethanol was 1:4), and 
the concentration of ALA encapsulated in the li-
posome was detected. The trapping efficiency of 
the liposome for ALA was estimated by the Eq. 
(1). Here, the concentration of ALA in the solution 
used for preparing the liposome dispersion was 
0.28 M, as mentioned above. 
5. Measurement of in Vitro skin permeation of ALA
In vitro skin permeation of ALA in the lipo-
some through YMP full-thickness skin was de-
termined with a Franz-type diffusion cell having 
donor and receptor compartments. The available 
diffusion area of the skin was 1.77 cm2, and the 
volume of the receptor compartment was 12 mL. 
The skin was mounted in the Franz-type diffusion 
cell. The ALA-loaded liposome dispersion pre-
pared was added in the donor compartment, and 
phosphate buffered saline (pH: 7.4) was poured 
into the receptor compartment. After the cell stood 
for a certain time at 37 °C with stirring of the 
buffered saline with a magnetic stirrer, 200 μL of 
buffered saline in the receptor compartment was 
taken out. The concentration of ALA permeated 
was then measured, and the cumulative amount of 
permeated ALA per unit skin area was calculated. 
III. Results and discussion 
It is well known that Bangam’s method pro-
duces multilamellar vesicle types of liposomes 
and that the polarization microscopic observation 
of the liposome provides us a cross Nicol texture 
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coming from the multilamellar structure of the 
lipid membrane 10). When observing the prepared 
liposome dispersion with a polarization microsco-
py, we could recognize a cross Nicol texture, as 
expected. Additionally, the concentration of ALA 
encapsulated in the liposome was 2.0 mM; the 
trapping efficiency of the liposome for ALA was 
estimated at 0.71 %. These findings indicate that 
ALA-loaded liposomes can be constructed obvi-
ously by Bangam’s method in this study. 
Figure 1 represents the change in cumula-
tive amount of permeated ALA per unit skin area 
with the permeation time. Here, we employed 
three types of ALA systems for the measurement: 
ALA-loaded liposome dispersion, aqueous ALA 
solution including empty liposomes, and aqueous 
ALA solution (ALA alone). The concentration of 
ALA was 2 mM in all of the systems. The aque-
ous ALA solution including empty liposomes was 
prepared by the same method as the ALA-loaded 
liposome dispersion using 2 mM ALA without the 
dialysis. In consideration of the fact that the trap-
ping efficiency of ALA in the ALA-loaded lipo-
some was 0.71 %, as mentioned above, we guess 
that a large number of ALA are in the outer water 
phase, but not in the inner water phase. 
As can be seen from Fig. 1, the cumulative 
amount of permeated ALA increases in increasing 
permeation time. In comparison at the same per-
meation time, the cumulative amount of permeat-
ed ALA in the ALA-loaded liposome dispersion 
is the largest among the systems; the cumulative 
amount of ALA in the aqueous ALA solution in-
cluding empty liposomes is almost equal to that in 
the aqueous ALA solution. 
We evaluated permeation parameters estimat-
ed from the permeation profile shown in Fig. 1 
10). The flux, J, of ALA permeated through YMP 
skin was calculated from the slope of the steady-
state portion of the permeation profile between the 
cumulative amount of permeated ALA per unit 
skin area and the permeation time. Besides, the 
lag time, Tlag was estimated from the linear extrap-
olation of the steady-state portion to the X-axis 
of the permeation profile. We then estimated the 
J and Tlag from the linear relationship using three 
plots at the permeation time more than 48 hr in 
Fig. 1. Furthermore, we calculated the permeabil-
ity coefficient of ALA in the stratum corneum, Kp, 
diffusion coefficient of ALA in the stratum corne-
um, D, and partition coefficient of ALA between 
the stratum corneum and the solution in the donor 
compartment, K, using Eqs. (2) to (4) below: 
where CD is the initial concentration of ALA in the 
donor compartment, L the diffusion path length, 
that is, the thickness of YMP skin. According to 
the previous paper, we assigned 0.2 cm to L in this 
study 11). 
The permeation parameters calculated are 
summarized in Table 1. As a result, the Kp of 
ALA in the ALA-loaded liposome dispersion is 
about 2 times larger than those in any other sys-
tem (p<0.05 by Welch’s t-Test vs. aqueous ALA 
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Fig. 1  Change in cumulative amount of permeated 
ALA per unit skin area with permeation time. 
Data show mean±SD (n=3).
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solution). Moreover, the Kp in the aqueous ALA 
solution including empty liposomes is almost the 
same as that in the aqueous ALA solution. Kp is the 
most important parameter for skin permeation of 
drugs. It can evaluate the skin permeation without 
depending on the initial concentration of the drug 
in the donor compartment; the larger the Kp of the 
drug is, the greater its skin permeation is. There-
fore, the ALA-loaded liposome dispersion is su-
perior in permeating ALA through the YMP skin. 
The Tlag is the time at the beginning of the 
steady-state portion of the permeation profile be-
tween the cumulative amount of permeated ALA 
per unit skin area and the permeation time. Table 
1 shows that Tlag is almost constant in any system.
Equation (3) indicates that the Kp is closely 
related to K and D. Since the D in any permeation 
system is almost constant, shown in Table 1, the 
change in Kp is attributed to K alone. Table 1 de-
picts that the K of the ALA-loaded liposome dis-
persion is the largest among the systems. There-
fore, the enhancement in skin permeation of ALA 
by the ALA-loaded liposome dispersion is caused 
by the enlargement of partition of ALA into the 
stratum corneum. 
It is well known that the structures of stratum 
corneum are changed by phospholipids, leading to 
enhancement of drug penetration 12). But there is 
little difference in Kp of the aqueous ALA solution 
with and without empty liposomes in this study. 
We consider that the enhancement of ALA perme-
ation by the ALA-loaded liposome is independent 
of the permeation enhancement effect of phospho-
lipids. 
Intact skin penetration of liposomes carrying 
drugs was suggested in the first report on lipo-
somes as skin drug delivery systems 7). Assum-
ing that the ALA-loaded liposome penetrates and 
passes through the skin, we expect that the D of 
ALA is different from that in the aqueous ALA 
solution. As can be seen from Table 1, however, 
the D of ALA in the ALA-loaded liposome dis-
persion is almost equal to that in the aqueous ALA 
solution. It is then unlikely that the skin perme-
ation of ALA-loaded liposomes enlarges the par-
tition of ALA into the stratum corneum and pro-
motes skin permeation of ALA. 
It was reported that liposomes adhere onto the 
skin surface with fusing and/or mixing with the 
lipid matrix of stratum corneum, releasing drugs 
into stratum corneum 13). This mechanism could 
reasonably explain the results in this study. That 
is, the release of ALA from liposomes on the skin 
surface elevates the concentration of ALA around 
the skin and promotes the partition of ALA into 
the stratum corneum, resulting in the acceleration 
of ALA penetration through the stratum corneum. 
Moreover, since ALA independently permeates 
through the skin in this way, we suggest that the 
D of ALA in the ALA-loaded liposome dispersion 
corresponds to that in the aqueous ALA solution.  
In consequence, the ALA-loaded liposome 
dispersion promotes the partition of ALA into the 
skin and is effective to enhance the skin perme-
ation of ALA. The interest in mechanism of drug 
permeation with liposomes warrants further inves-
tigation. 
  
      
        
        
      
       
        
       
      
       
      
       
        
 
 
 
 
        
       
        
       
         
    
         
       
       
       
      
       
     
         
      
       
      
       
       
          
     
     
      
         
      
      
        
        
     
       
          
      
         
        
        
     
      
      
       
  
        
     
     
       
       
      
       
Table 1  Skin permeation parameters estimated from permeation profile. 
9.50±2.321.91±0.1935.2±3.508.95±1.57*ALA-loaded liposome dispersion
4.58±1.651.93±0.1934.8±3.514.33±1.09Aqueous ALA solution (ALA alone)
1.66±0.07
D (x 10-4 cm2/hr)
6.51±1.39
K (x 10-1)
40.3±1.56
Tlag (hr)
5.40±1.18Aqueous ALA solution including empty liposomes
Kp (x 10-4 cm/hr)
*: p<0.05 by Welch’s t-Test vs. aqueous ALA solution
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